Dan Shellenbarger, MBA
Dan is a Partner in Oliver Wyman’s Health and Life Sciences practice focusing on issues of revenue growth and operational effectiveness.
Dan spent 10 years working on strategic sales and marketing issues in the pharmaceutical and biotechnology sectors with ZS Associates. Through engagements with clients in the US as well as Europe, South America and Asia, Dan became a trusted advisor to leading biotechnology and pharmaceutical clients on issues spanning all aspects of go-to-market strategy. Dan joined ChapterHouse in 2007, becoming part of Oliver Wyman when the two firms joined forces in the summer of 2008. Dan holds a BBA from the University of Michigan and an MBA from Duke University.